Notice of Results
GENinCode Plc has announced that its unaudited interim results for the six months ended 30 June 2026 will be released on Tuesday, 29 September 2026, with an analyst briefing scheduled for the same day. The company, which focuses on the prevention of cardiovascular disease and ovarian cancer through predictive genetics, will provide these financial updates to equity research analysts.
Select text to share a quote on X · sign in to keep highlights & notes in your GENI notes
Oxford, UK. GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease and ovarian cancer, announces that it will release its unaudited interim results for the six months ended 30 June 2026 on Tuesday, 29 September 2026.
Analyst briefing
A briefing open to equity research analysts will take place on Tuesday, 29 September 2026 at 09.30am BST. To register and for more details please contact Walbrook PR on genincode@walbrookpr.com.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.